Pfizer close to acquiring Metsera for $7.3B, targeting breakthrough obesity drug

Pfizer is making a bold move in the pharmaceutical world by closing in on a $7.3 billion deal to acquire Metsera, a biotech firm focused on next-generation anti-obesity drugs, news platform Financial Times reported on Monday. ...